Christophe Legendre

Christophe Legendre's AcademicInfluence.com Rankings

Christophe Legendre

Biology

#15202

World Rank

#19132

Historical Rank

Immunology

#1052

World Rank

#1078

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Christophe Legendre Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Christophe Legendre's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups (2010) (751)
Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients (1996) (437)
Optimization of Initial Tacrolimus Dose Using Pharmacogenetic Testing (2010) (350)
Antibody‐Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure (2010) (318)
Outcome of Subclinical Antibody‐Mediated Rejection in Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (2009) (307)
IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION: SYSTEMIC CYTOKINE RELEASE AND MODULATION BY CORTICOSTEROIDS (1990) (289)
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. (1989) (252)
Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal Transplantation (2012) (248)
Hydroxyethylstarch and osmotic-nephrosis- like lesions in kidney transplantation (1993) (240)
Significance of C4d Banff Scores in Early Protocol Biopsies of Kidney Transplant Recipients with Preformed Donor‐Specific Antibodies (DSA) (2011) (228)
The ORION Study: Comparison of Two Sirolimus‐Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients (2011) (202)
Clinical Operational Tolerance after Kidney Transplantation (2006) (182)
The long-term virologic and pathologic impact of renal transplantation on chronic hepatitis B virus infection. (1996) (161)
Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. (1998) (161)
Plasma cystatin C is superior to 24-h creatinine clearance and plasma creatinine for estimation of glomerular filtration rate 3 months after kidney transplantation. (2000) (160)
Complement Mutation‐Associated De Novo Thrombotic Microangiopathy Following Kidney Transplantation (2008) (159)
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. (1997) (154)
Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients. (1994) (150)
Cyclosporine‐Induced Endoplasmic Reticulum Stress Triggers Tubular Phenotypic Changes and Death (2008) (149)
Sirolimus May Reduce Fertility in Male Renal Transplant Recipients (2008) (139)
Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients (2010) (137)
Cytomegalovirus Incidence Between Everolimus Versus Mycophenolate in De Novo Renal Transplants: Pooled Analysis of Three Clinical Trials (2011) (135)
Peripheral microchimerism in long-term cadaveric-kidney allograft recipients (1994) (129)
Sirolimus Conversion for Patients with Posttransplant Kaposi's Sarcoma (2006) (128)
Kaposi sarcoma in transplantation. (2008) (125)
The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. (1995) (122)
A Simple Clinico‐Histopathological Composite Scoring System Is Highly Predictive of Graft Outcomes in Marginal Donors (2008) (122)
Severe evolution of chronic hepatitis C in renal transplantation: a case control study. (2002) (122)
Bortezomib as the Sole Post‐Renal Transplantation Desensitization Agent Does Not Decrease Donor‐Specific Anti‐HLA Antibodies (2010) (120)
HUMAN HERPES VIRUS-8 AND OTHER RISK FACTORS FOR KAPOSI'S SARCOMA IN KIDNEY TRANSPLANT RECIPIENTS1 (1999) (118)
Changes in plasma cystatin C after renal transplantation and acute rejection in adults. (1999) (117)
Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. (2006) (112)
Specificity of Histological Markers of Long‐Term CNI Nephrotoxicity in Kidney‐Transplant Recipients Under Low‐Dose Cyclosporine Therapy (2011) (111)
Intensive and Prolonged Treatment of Focal and Segmental Glomerulosclerosis Recurrence in Adult Kidney Transplant Recipients: A Pilot Study (2009) (111)
Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. (1994) (110)
Humoral and Cellular Immune Responses after Influenza Vaccination in Kidney Transplant Recipients (2009) (108)
Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites. (1991) (102)
Differential in situ expression of cytokines in renal allograft rejection. (1991) (100)
Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes (2013) (96)
Chronic hepatitis in kidney allograft recipients (1990) (96)
The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty‐Seven Cases (2012) (92)
Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. (1997) (91)
Incidence, Risk Factors and Clinical Consequences of Neutropenia Following Kidney Transplantation: A Retrospective Study (2009) (89)
HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients. (2000) (83)
High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study (2010) (81)
Renal Transplantation in HIV‐Infected Patients: The Paris Experience (2010) (78)
Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant Antibodies (2010) (78)
Differences in the frequency and function of HHV8-specific CD8 T cells between asymptomatic HHV8 infection and Kaposi sarcoma. (2006) (78)
Donor‐Estimated GFR as an Appropriate Criterion for Allocation of ECD Kidneys into Single or Dual Kidney Transplantation (2009) (76)
Prognostic value of quantitative Kaposi sarcoma--associated herpesvirus load in posttransplantation Kaposi sarcoma. (2002) (75)
Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation. (1992) (75)
Genetic basis of nonresponse to hepatitis B vaccine in hemodialyzed patients. (1990) (75)
Global Transplantation COVID Report March 2020 (2020) (72)
Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level? (2010) (65)
The Impact of Preexisting or Acquired Kaposi Sarcoma Herpesvirus Infection in Kidney Transplant Recipients on Morbidity and Survival (2009) (63)
Kidney Transplant Recipients Carrying the CYP3A4*22 Allelic Variant Have Reduced Tacrolimus Clearance and Often Reach Supratherapeutic Tacrolimus Concentrations (2015) (61)
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis. (1996) (59)
Anti‐Factor H Autoantibodies in a Fifth Renal Transplant Recipient with Atypical Hemolytic and Uremic Syndrome (2009) (58)
Posttransplant Prophylactic Intravenous Immunoglobulin in Kidney Transplant Patients at High Immunological Risk: A Pilot Study (2007) (57)
A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy. (1997) (55)
Hepatitis C virus in kidney recipients (1992) (55)
Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout. (1997) (53)
Effect of an Early Switch to Belatacept Among Calcineurin Inhibitor–Intolerant Graft Recipients of Kidneys From Extended‐Criteria Donors (2016) (51)
The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells. (1990) (49)
Metabolic stress promotes renal tubular inflammation by triggering the unfolded protein response (2011) (48)
Monitoring of azathioprine-induced immunosuppression with thiopurine methyltransferase activity in kidney transplant recipients. (1995) (48)
Comparison of clinical outcome following coronary stenting or balloon angioplasty in dialysis versus non-dialysis patients. (2000) (48)
Long‐Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype (2016) (46)
Human Herpesvirus 8 (HHV8) Transmission and Related Morbidity in Organ Recipients (2013) (45)
Impact and evolution of peliosis hepatis in renal transplant recipients. (1994) (44)
Genome‐Wide Association Study of Acute Renal Graft Rejection (2016) (44)
Recurrent 2,8‐Dihydroxyadenine Nephropathy: A Rare but Preventable Cause of Renal Allograft Failure (2014) (43)
Outcome of Kidney Transplantations Performed With Preformed Donor‐Specific Antibodies of Unknown Etiology (2014) (43)
Interstitial Fibrosis Evolution on Early Sequential Screening Renal Allograft Biopsies Using Quantitative Image Analysis (2011) (42)
Risk of Antibody‐Mediated Rejection in Kidney Transplant Recipients With Anti‐HLA‐C Donor‐Specific Antibodies (2014) (39)
Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients. (2001) (36)
Microchimerism frequency two to thirty years after cadaveric kidney transplantation. (1994) (36)
Study of the in vitro effect on glomerular albumin permselectivity of serum before and after renal transplantation in focal segmental glomerulosclerosis. (1997) (35)
Severe infections requiring intensive care unit admission in kidney transplant recipients: impact on graft outcome (2014) (34)
Selection of transplantation procedures and perioperative management in primary hyperoxaluria type 1. (1995) (33)
Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient. (2000) (32)
A Tribute to Jean Hamburger's Contribution to Organ Transplantation (2010) (31)
Thiopurine-methyl-transferase activity to assess azathioprine myelotoxicity in renal transplant recipients (1993) (31)
Carotid atherosclerosis in renal transplant recipients. (2000) (27)
Surgical Treatment of Destructive Cervical Spondyloarthropathy With Neurologic Impairment in Hemodialysis Patients (2006) (27)
Gd-DOTA-enhanced MR imaging and color Doppler US of renal allograft necrosis. (1992) (27)
CD80 expression is decreased in hyperplastic lymph nodes of HIV+ patients. (1998) (25)
Clinical Use of OKT3: The Role of Cytokine Release and Xenosensitization (1988) (24)
Hepatitis and solid organ transplantation. (2000) (24)
Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study. (2019) (24)
Early diagnosis of renal function recovery by cystatin C in renal allograft recipients. (2000) (23)
Hemolytic uremic syndrome. Recurrence after renal transplantation. Groupe Coopératif de l'Ile-de-France (GCIF). (2000) (22)
CD40/CD40L interactions and cytokines regulate HIV replication in B cells in vitro. (1996) (22)
Dramatic Improvement of Severe Cryptococcosis‐Induced Immune Reconstitution Syndrome With Adalimumab in a Renal Transplant Recipient (2015) (20)
Recent issues concerning renal transplantation in systemic lupus erythematosus patients. (2001) (19)
Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation (2017) (19)
Absence of hepatitis delta virus infection in chronic hemodialysis and kidney transplant patients in france. (1992) (19)
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection. (1989) (18)
Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release. (1993) (17)
MR Imaging of Renal Transplant Rejection (1991) (17)
Treatment and prognosis of post-transplant lymphoproliferative disease. (1997) (17)
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriers. (2011) (16)
Long-term outcome of hepatitis C infection after liver transplantation. (1996) (15)
HLA antigens in patients with recrudescent herpes simplex infections. (1982) (14)
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: A case‐controlled study (1993) (14)
Crescentic glomerulonephritis and centrocytic lymphoma. (1999) (14)
Effects of interleukin-2 on hepatitis B vaccination in uraemic patients (1994) (14)
The Nephroprotective Properties of Recombinant Human Erythropoietin in Kidney Transplantation: Experimental Facts and Clinical Proofs (2012) (13)
Is there a place for isolated renal transplantation in the treatment of primary hyperoxaluria type 1? Experience from Paris. (1995) (12)
Predictive Modeling of Tacrolimus Dose Requirement Based on High‐Throughput Genetic Screening (2017) (12)
In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Differential regulation of TNF-sR55 and TNF-sR75. (1995) (12)
Effect of immunosuppression on the incidence of lymphoma formation (1992) (12)
Hypertension in kidney transplantation (1989) (11)
Successful kidney transplantation in a patient with microscopic polyarteritis and positive ANCA. (1993) (11)
Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody. (1990) (10)
Differential in situ expression of cytokine genes in human renal rejection. (1991) (10)
Complete regression of a major hyperprolactinaemia after renal transplantation. (1999) (9)
The role of complement inhibition in kidney transplantation (2017) (9)
Anti-endothelial and epithelial antibodies in renal transplantation. (1998) (8)
Anti-HLA sensitization after renal transplant excision: a retrospective study in 84 patients. (1996) (8)
Cytomegalovirus infections after kidney transplantation: identical risk whether donor or recipient is the virus carrier. (1991) (8)
Prospective serial evaluation of cell adhesion molecule expression in transplanted kidneys. (1995) (8)
PARVG gene polymorphism and operational renal allograft tolerance. (2012) (8)
Chronic rejection and cell growth factors. (1996) (7)
Angiotensin-converting enzyme (ACE) inhibitors have been reported to induce or worsen anemia in patients on hemodialysis. (1991) (7)
In situ expression of cell growth factors in human renal chronic graft rejection. (1997) (7)
B cell-driven HIV type 1 expression in T cells: an essential role of CD86 costimulatory molecule. (1998) (7)
Impact of co-infection by hepatitis B virus and hepatitis C virus in renal transplantation. (1998) (7)
Quantitative study of beta1-integrin expression and fibronectin interaction profile of T lymphocytes in vitro infected with HIV. (2000) (6)
[National survey on temporary vascular access for hemodialysis]. (1994) (6)
Human immunodeficiency virus and the complement system. (1997) (6)
Emergence of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient. (2000) (6)
Clinical significance of T cell monitoring during antithymocyte globulin induction in renal transplantation. (1997) (6)
Sequential measurements of urinary albumin in recipients of renal allografts. (1991) (6)
Vascular rupture complicating transluminal angioplasty applied on a failed dialysis vascular access in a patient under chronic steroid therapy (1997) (5)
[Preoperative selective embolization allowing a partial splenectomy for splenic hamartoma]. (2003) (5)
Significance of hypoperfused territories demonstrated by color Doppler ultrasonography following renal transplantation. (1994) (5)
Segmental necrosis of the ascending colon in haemodialysis patients. (1996) (5)
Cyclosporine Abrogates De Novo Generation of Tregs Independently of IL‐2 (2007) (5)
Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B. (1994) (5)
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion. (2000) (4)
The First Transplant Kidney Biopsy Ever Performed (2013) (4)
Effects of interleukin-2 on hepatitis B vaccination in uraemic patients. (1994) (4)
[New immunosuppressive drugs and diabetes]. (2001) (4)
Clinical consequences of the polymorphism of azathioprine metabolism. (2000) (4)
Late histological recurrence of familial Mediterranean fever amyloidosis after renal transplantation. (1994) (4)
[Tunnelized double femoral catheters. A technique for vascular access in hemodialysis]. (1993) (4)
[Hydroxyethylstarch and osmotic nephrosis]. (1994) (4)
[Pharmacology of mycophenolate mofetil: recent data and clinical consequences]. (2001) (4)
[Renal venous thrombosis: a forgotten complication of acute pyelonephritis]. (1997) (4)
Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis. (2002) (4)
[Tunneled double femoral catheters: emergency vascular access for hemodialysis]. (1994) (3)
[Hypoparathyroidism after thyroid surgery]. (1994) (3)
Cryptococcosis after renal transplantation. (1995) (3)
Renal allograft necrosis: value of color Doppler ultrasound and Gd-DOTA-enhanced magnetic resonance imaging. (1994) (3)
PROSPECTIVE RANDOMIZED STUDY OF PHARMACOGENETIC ADAPTATION OF TACROLIMUS TREATMENT AFTER RENAL TRANSPLANTATION: 529 (2008) (3)
[Rapamycine and mTOR inhibitors: from bench to bedside]. (2006) (3)
Systemic chimerism in cadaveric kidney allograft recipients. (1995) (3)
[Kidney harvesting in living donors with manually assisted laparoscopy: technique and results]. (2000) (3)
Efficacy of adenine arabinoside 5'-monophosphate in kidney recipients with chronic active hepatitis B: a pilot study. (1993) (3)
[T CD57+ lymphocytes in kidney transplanted patients. Phenotypic and functional study]. (1992) (3)
4D.05: RECOVERY OF VASCULAR HEALTH AFTER KIDNEY TRANSPLANTATION (2015) (2)
[Effect of pregnancy on renal function after transplantation]. (1992) (2)
[Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors]. (2009) (2)
B Cells in the Line of Sight of HIV‐1 (2001) (2)
[Viral hepatitis in hemodialysis and renal transplantation patients]. (1994) (2)
LOWERING CYCLOSPORINE DOSE IS NOT ASSOCIATED WITH AN INCREASED RISK OF GASTRO-INTESTINAL ADVERSE EVENTS NOR THE NEED FOR DOSAGE DECREASE OF MYCOPHENOLATE MOFETIL. (2004) (2)
Potential involvement of growth factors in the proliferation of arteriolar smooth muscle cells during chronic graft rejection. (1996) (2)
Strategy of cytomegalovirus infection prevention in renal transplantation. (1994) (2)
In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment. (1990) (2)
Hairy-cell leukaemia in a renal transplant recipient. (1996) (2)
Amydopyrine pancytopenia: detection of leucocytotoxic antibodies by a 51Cr-release test. (1979) (2)
Anti-HLA sensitization against graft specificities after kidney transplantation: use of PRA-stat ELISA. (2000) (2)
Activation lymphocytaire T induite in vivo par la première injection de l'anticorps monoclonal OKT3 (1988) (2)
661Morbidity of the simultaneous pancreas-kidney transplantation with enteric drainage of exocrine pancreatic secretion (2005) (1)
Plasma cystatin C: a better marker of glomerular filtration rate than creatinine in kidney transplantation (2000) (1)
The use of directly frozen cells in LDA assay. (2008) (1)
First dose OKT3-induced release of endothelin in renal transplant recipients. (1993) (1)
Epidemiology and impact on renal trans (1992) (1)
Delineating the Picture of Renal Graft Injury in 2011 (2011) (1)
[Hand-assisted laparoscopic bi-nephrectomy for refractory arterial hypertension in kidney transplantation]. (2001) (1)
Falsely Increased Values for Rabbit Immunoglobulin-based Nephelometric Immunoassays Attributable to Human Anti-Rabbit Antibodies (2000) (1)
CD 80 expression is decreased in hyperplastic lymph nodes of HIV F patients (1998) (1)
Chronic rejection: is allograft destruction an inevitable phenomenon? (1996) (1)
[Aseptic osteonecrosis of the knee induced by corticoids. MRI aspects]. (1992) (1)
Can we improve the results of simultaneous pancreas-kidney transplantation? (1998) (1)
Histologic evolution of kidney graft after combined pancreas-kidney transplantation. (2000) (1)
[Hepatitis C in kidney recipients. Epidemiology and impact on kidney transplantation]. (1991) (0)
Renal Transplantation (1968) (0)
[T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies]. (1988) (0)
TRANSMISSION OF HUMAN HERPESVIRUS 8 THROUGH THE GRAFT. (2004) (0)
[Interest of screening biopsies in renal transplantation]. (2008) (0)
CYA WITHDRAWAL IN STABLE RENAL TRANSPLANT RECIPIENTS AFTER AZA - MMF SWITCH: A PILOT STUDY. (1999) (0)
[Positioning of hemodialysis catheters after locating the internal jugular vein by echo-Doppler]. (1994) (0)
[Screening biopsies in kidney transplantation: from subclinical acute rejection to chronic allograft lesions]. (2008) (0)
Results of kidney transplantation at Necker Hospital. (1988) (0)
NO EXCLUSION OF HHV-8 INFECTED DONORS AND RECIPIENTS FOR KIDNEY TRANSPLANTATION: A FRENCH PROSPECTIVE NATIONAL COHORT: 636 (2008) (0)
The First Transplant Kidney Biopsy Ever Performed: Letter to the Editor (2013) (0)
Kidney transplantation at Necker Hospital: the most recent 5-year period (2004-2009). (2010) (0)
Outcome of patients admitted for severe coma in an intensive care unit. (1996) (0)
O1 SURVEILLANCE BIOPSY-DRIVEN STEROID WITHDRAWAL: IMPACT ON KIDNEY TRANSPLANT OUTCOME (2016) (0)
Acyclovir in preventing cytomegalovirus infection in kidney transplant recipients: a case-controlled study. (1993) (0)
[Hepatotropic virus and renal transplantation]. (1996) (0)
Systemic chimerism in long-term cadaveric kidney allograft recipients (1994) (0)
[Homozygote deficiency of thiopurine methyltransferase. A contraindication to the use of azathioprine in kidney transplantation]. (1995) (0)
Hepatitis viruses and kidney transplantation (1996) (0)
INTERSTITIAL FIBROSIS EVOLUTION ON EARLY SEQUENTIAL ROUTINE RENAL ALLOGRAFT BIOPSIES USING NUMERICAL QUANTIFICATION ANALYSIS: 509 (2010) (0)
Zuber AJT 2012 (2013) (0)
Humoral and cellular cross-match tests before bone-marrow transplantation [proceedings]. (1978) (0)
Hydroxyethylstarch and renal function in kidney transplant recipients (1997) (0)
Best Abstracts (2004) (0)
Assessment of rneal function following kidney transplantatioin using plasma cystatin C (1999) (0)
[What are the current recommendations for polyclonal antilymphocyte antibody induction in kidney transplantation?]. (2000) (0)
O881 - Microchimerism frequency and kinetics in cadaveric kidney allograft recipients (1996) (0)
Abstracts of the 16th Annual Congress of the French Speaking Society of Transplantation, Liège, Belgium, 6-9 December 2016. (2017) (0)

This paper list is powered by the following services:

Christophe Legendre's Academic­Influence.com Rankings

Why Is Christophe Legendre Influential?

Christophe Legendre's Published Works

Published Works

Christophe Legendre's AcademicInfluence.com Rankings